Cetera Investment Advisers
BMY icon

Cetera Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Cetera Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$36 – 4821
2025
Q4 		$36 Sell
100
-100
-50% -$4.81K ﹤0.01% 4680
2025
Q3 		$336 Buy
200
+100
+100% +$4.67K ﹤0.01% 4561
2025
Q2 		$109 Buy
+100
New +$4.91K ﹤0.01% 4084

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cetera Investment Advisers's BMY Position: Q2 2026 in Review

Cetera Investment Advisers increased its Bristol-Myers Squibb (BMY) stake by 7.4% in Q2 2026, buying an estimated $3.5M and bringing the position to 883,910 shares worth $50.9M. The position accounts for 0.05% of the portfolio, ranked #402.

Cetera Investment Advisers first reported a position in BMY in Q4 2015 and has held it in 43 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cetera Investment Advisers held 883,910 shares of Bristol-Myers Squibb worth $50.9M as of Q2 2026.
  • Cetera Investment Advisers bought 60,962 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.5M.
  • Bristol-Myers Squibb made up 0.05% of Cetera Investment Advisers's portfolio in Q2 2026, its #402 holding.
  • Cetera Investment Advisers first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 43 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.